GHGuardant Health Inc
GH
Guardant Health Inc4,912
Mkt Cap
$11.14BVolume
1.51M52W High
$120.7452W Low
$36.36PE Ratio
-25.63GH Fundamentals
Price
$84.96Prev Close
$85.18Open
$87.5650D MA
$101.37Beta
1.41Avg. Volume
2.25MEPS (Annual)
-$3.32P/B
-111.76Rev/Employee
$391,867.92$13,314.24
Musa Tariq Sells 348 Shares of Guardant Health (NASDAQ:GH) Stock
Guardant Health, Inc. (NASDAQ:GH - Get Free Report) Director Musa Tariq sold 348 shares of the firm's stock in a transaction on Wednesday, March 18th. The shares were sold at an average price of $88.09, for a total transaction of $30,655.32. Following the sale, the director directly owned 8,394...
MarketBeat·4d ago
Insider Selling: Guardant Health (NASDAQ:GH) Director Sells 348 Shares of Stock
Guardant Health, Inc. (NASDAQ:GH - Get Free Report) Director Musa Tariq sold 348 shares of the business's stock in a transaction dated Wednesday, March 18th. The shares were sold at an average price of $88.09, for a total transaction of $30,655.32. Following the sale, the director directly owned...
MarketBeat·4d ago
Guardant Health to Present 28 Abstracts Highlighting Advances in Tumor Typing, Therapy Selection and Expanded Utility of Multiomic Tissue and Liquid Biopsy Testing at AACR 2026
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research collaborators will present 28 abstracts, including 3 oral sessions, showcasing...
Business Wire·6d ago
Guardant Health (NASDAQ:GH) CFO Michael Brian Bell Sells 3,000 Shares
Guardant Health, Inc. (NASDAQ:GH - Get Free Report) CFO Michael Brian Bell sold 3,000 shares of the firm's stock in a transaction on Monday, March 16th. The shares were sold at an average price of...
MarketBeat·6d ago
Guardant Health (NASDAQ:GH) CFO Sells $261,120.00 in Stock
Guardant Health, Inc. (NASDAQ:GH - Get Free Report) CFO Michael Brian Bell sold 3,000 shares of the stock in a transaction dated Monday, March 16th. The stock was sold at an average price of $87.04...
MarketBeat·6d ago
Guardant Health Touts Quest Deal for Shield, Guardant360 Growth and FDA Milestones at Leerink Conference
Guardant Health (NASDAQ:GH) executives highlighted new commercial initiatives for its Shield colorectal cancer screening test, continued growth drivers for its Guardant360 therapy selection...
MarketBeat·7d ago
Algert Global LLC Raises Stock Holdings in Guardant Health, Inc. $GH
Algert Global LLC raised its holdings in Guardant Health, Inc. (NASDAQ:GH - Free Report) by 169.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·7d ago
Guardant Health, Inc. $GH Shares Bought by Iron Triangle Partners LP
Iron Triangle Partners LP grew its holdings in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) by 33.3% during the third quarter, according to its most recent Form 13F filing with the SEC...
MarketBeat·8d ago
Guardant Health Launches Shield Multi-Cancer Detection (MCD) Test in Multiple Markets in Asia with Manulife Partnership
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the launch of the Shield multi-cancer detection (MCD) laboratory developed test (LDT) in multiple markets in...
Business Wire·8d ago
HighVista Strategies LLC Acquires 36,318 Shares of Guardant Health, Inc. $GH
HighVista Strategies LLC increased its holdings in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) by 128.5% during the third quarter, according to the company in its most recent disclosure...
MarketBeat·8d ago
<
1
2
...
>